Strong Revenue Growth
Orthofix reported a 6% year-over-year increase in global net sales reaching $203.4 million, with significant contributions from the U.S. Spine and Orthopedics segments.
U.S. Spine Fixation Segment Performance
The U.S. Spine Fixation segment saw an 8% increase in net sales, with procedural volume up 10%, driven by the 7D FLASH navigation system and distributor transitions.
Orthopedics Business Growth
The U.S. Orthopedics segment experienced 19% growth, marking the fifth consecutive quarter of double-digit growth, fueled by the successful global launch of TrueLok Elevate.
Bone Growth Therapies Achievement
Bone Growth Therapies achieved 6% growth, outperforming the market, supported by cross-selling opportunities.
Positive Free Cash Flow
Orthofix generated a positive free cash flow of $2.5 million, ending the quarter with $65.9 million in total cash, supporting continued innovation and financial flexibility.
EBITDA Margin Expansion
The company reported its seventh consecutive quarter of adjusted EBITDA margin expansion, highlighting operational efficiency and cost management.